ABMD
$298.28
Abiomed
($21.50)
(6.72%)
ABMD
Earnings Whisper ®
N/A
3rd Quarter December 2018
Consensus:  $0.94
Revenue:  $195.17 Mil
Thursday
Jan 31
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ABMD reports earnings?
Beat
Meet
Miss

Where is ABMD's stock price going from here?
Up
Flat
Down
Stock chart of ABMD
Analysts
Summary of analysts' recommendations for ABMD
Score
Grade
Pivots
Resistance
$346.26
$339.21
$329.49

$322.44

Support
$312.72
$305.67
$295.95
Tweet
Growth
Description
Abiomed, Inc. is a developer, manufacturer and marketer of medical products designed to safely and effectively assist or replace the pumping function of the failing heart. The company currently manufactures and sells the BVS-5000, a temporary heart assist device, which is approved by the U.S. Food and Drug Administration for the temporary treatment of all patients with failing but potentially recoverable hearts. The company is also engaged in research and development relating to other devices to support the pumping function of the heart.
Peers
Boston ScientificStrykerAbbott LaboratoriesBecton, DickinsonBaxter InternationalWatersIntegra LifeSciences Holdings3MResMedTeleflex